The Quantellect read.As of Nov 19, 2026, 7 active firms cover Replimune Group Inc: 5 rate it Buy or better, 1 sit at Neutral, and 1 rate it Sell or worse, a buy consensus. The target range is very wide, $2.00 to $21.00 (about 10.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $14.60 sits 26% below the current $19.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.39 next quarter toward $-0.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 active firms
Buy
Strong Buy00%
Buy571%
Neutral114%
Sell114%
Strong Sell00%
Based on 7 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$14.60
-26.3% downside
Average target across 5 active firms as of Nov 19, 2026 vs $19.80 current
Highest Target$21.00
Average Target$14.60
Lowest Target$2.00
Detailed analyst forecasts for REPL
Showing 1–7 of 7 named analysts shown · 7 active firms in the rating projection
As of Nov 19, 2026, 5 of 7 active firms rate REPL a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
REPL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.39
Range $-0.42 – $-0.33 · 3 analysts · -49% YoY
Next period, 3 analysts expect Replimune Group Inc to earn $-0.39 a share (range $-0.42 – $-0.33), versus $-0.76 a year earlier. Full-year consensus is $-2.05, growing to $-0.67 the year after.
REVENUE · NEXT QUARTER
$17.1M
Range $0 – $36.7M · 3 analysts
Revenue is expected to reach $17.1M (range $0 – $36.7M). Full-year consensus is $38.0M, rising to $208.8M next year.
Top analysts covering Replimune Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on REPL.
#1
Peter Lawson
Barclays · Rank #89
Neutral
$3.00-84.8% to target
Overall win rate
45%
+ Follow
#2
Roger Song
Jefferies · Rank #122
Buy
$29.00+46.5% to target
Overall win rate
43%
+ Follow
#3
Anupam Rama
JP Morgan · Rank #171
Buy
$21.00+6.1% to target
Overall win rate
48%
+ Follow
#4
RB
Robert Burns
HC Wainwright & Co. · Rank #215
Sell
No targeton REPL
Overall win rate
42%
+ Follow
#5
Li Watsek
Cantor Fitzgerald · Rank #357
Buy
No targeton REPL
Overall win rate
38%
+ Follow
REPL stock forecast FAQ
What is REPL's average 12-month price target?+
The 5 active firms with a live target average $14.60 for Replimune Group Inc over the next 12 months, ranging from a $21.00 high to a $2.00 low, as of Nov 19, 2026.
Is REPL stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 7 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 1 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for REPL?+
The Street-high target is $21.00 (JP Morgan), and the Street-low is $2.00 (Jefferies). The average of all 5 active-firm targets is $14.60.
How many active Wall Street firms cover REPL?+
7 active firms have a recognized rating on Replimune Group Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering REPL?+
Among analysts who currently cover REPL, Peter Lawson of Barclays has the strongest overall Quantellect track record (Rank #89). Their current call is Neutral with a $3.00 target.
What is Replimune Group Inc's projected EPS for next quarter?+
The consensus estimate is $-0.39 per share (range $-0.42 – $-0.33) across 3 analysts. Full-year EPS is projected at $-2.05, rising to $-0.67 the following year.
How much revenue is Replimune Group Inc expected to report next quarter?+
Consensus revenue is $17.1M (range $0 – $36.7M). Full-year revenue is projected at $38.0M, growing to $208.8M next year.
Have analysts been upgrading or downgrading REPL lately?+
As of Nov 19, 2026, 5 of 7 active firms rate REPL a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their REPL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.